Sorrento Therapeutics, Inc. COMMON STOCK AMENDED AND RESTATED SALES AGREEMENTSales Agreement • December 3rd, 2021 • Sorrento Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 3rd, 2021 Company Industry Jurisdiction